Literature DB >> 17161930

S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease.

M Roca1, J Mota, P Alfonso, M Pocoví, P Giraldo.   

Abstract

Semi quantitative MRI is a very useful procedure for evaluating the bone marrow burden (BMB) in Gaucher disease (GD). Score systems have been applied to obtain a parameter for evaluating the severity of bone disease. Our purpose was to test a simple, reproducible and accurate score to evaluate bone marrow involvement in GD patients. MRI was performed in spine, pelvis and femora at diagnosis in 54 adult GD1 patients, 61.1% of whom were female. Three MRI patterns and punctuation in each location were defined: normal, 0; non-homogeneous infiltration subtypes reticular, 1; mottled, 2; diffuse, 3; and homogeneous infiltration, 4. This score was called Spanish-MRI (S-MRI). Two independent observers applied the S-MRI and bone marrow burden score and compared the differences using the non-parametric Mann-Whitney test. Correlation rank test was calculated. In 46 patients (85.2%), bone involvement was observed. Thirty-nine (72.3%) had their spine affected, 35 (64.8%) pelvis and 33 (61.2%) femora. Fourteen patients had bone infarcts, 14 avascular necrosis, 2 vertebral fractures and 2 bone crises. Correlation analysis between S-MRI and BMB was (r(2)=.675; p=.0001). No evidence of correlation was observed between CT activity and S-MRI nor between CT activity and BMB. We have found a relationship between genotype and bone infiltration according to S-MRI site and complications. S-MRI is a simple method that provides useful information to evaluate bone infiltration and detect silent complications. Our results correlated with the BMB score but offer higher sensitivity, specificity and accuracy for classifying the extent of bone disease.

Entities:  

Mesh:

Year:  2006        PMID: 17161930     DOI: 10.1016/j.ejrad.2006.11.024

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  17 in total

1.  Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?

Authors:  Benjamin Fedida; Sébastien Touraine; Jerôme Stirnemann; Nadia Belmatoug; Jean-Denis Laredo; David Petrover
Journal:  Eur Radiol       Date:  2015-04-16       Impact factor: 5.315

Review 2.  Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treatment.

Authors:  Siavash Piran; Dominick Amato
Journal:  J Inherit Metab Dis       Date:  2010-03-25       Impact factor: 4.982

Review 3.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

4.  Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG).

Authors:  R-M Javier; E Hachulla; C Rose; V Gressin; P Chérin; E Noël; C de Roux-Serratrice; D Dobbelaere; A Hartmann; R Jaussaud; P Clerson; B Grosbois; C Roux
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

Review 5.  Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.

Authors:  L van Dussen; E M Akkerman; C E M Hollak; A J Nederveen; M Maas
Journal:  J Inherit Metab Dis       Date:  2014-06-13       Impact factor: 4.982

Review 6.  An overview on bone manifestations in Gaucher disease.

Authors:  Peter Mikosch; Derralynn Hughes
Journal:  Wien Med Wochenschr       Date:  2010-12

7.  Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Abeer Fathy; Ahmed Megahed
Journal:  Skeletal Radiol       Date:  2012-06-21       Impact factor: 2.199

8.  Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project.

Authors:  Pilar Giraldo; Pilar Alfonso; Koldo Atutxa; María A Fernández-Galán; Abelardo Barez; Rafael Franco; Dora Alonso; Alejandro Martin; Paz Latre; Miguel Pocovi
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.

Authors:  L van Dussen; E J Hendriks; J E M Groener; R G Boot; C E M Hollak; J M F G Aerts
Journal:  J Inherit Metab Dis       Date:  2014-05-16       Impact factor: 4.982

10.  Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.

Authors:  Pilar Giraldo; Pilar Alfonso; Pilar Irún; Laura Gort; Amparo Chabás; Lluïsa Vilageliu; Daniel Grinberg; Clara M Sá Miranda; Miguel Pocovi
Journal:  Orphanet J Rare Dis       Date:  2012-03-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.